Ftse Mib
33.239,50
-0,56%
DAX
19.302,67
-0,55%
S&P 500
5.987,37
0,30%
NASDAQ
19.054,84
0,27%
Bitcoin
92.277,93
-0,86%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CervoMed Inc (CRVO) CervoMed Inc (CRVO) Notizie

CervoMed Inc

CRVO
8,76
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 12:06:10
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202421:09EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/11/202422:01EDGAR2Form 8-K - Current report
13/11/202414:00GLOBECervoMed Announces Key Senior Leadership Appointments
12/11/202413:00GLOBECervoMed Reports Third Quarter 2024 Financial Results and..
08/11/202415:55GLOBECervoMed Awarded the Prix Galien USA 2024 Prize for Best..
07/11/202414:30GLOBECervoMed to Participate in Upcoming Investor Conferences
04/11/202423:29EDGAR2Form 8-K - Current report
04/11/202414:00GLOBECervoMed Announces Key Takeaways from Oral Presentations at..
30/10/202413:00EDGAR2Form 8-K - Current report
29/10/202413:00GLOBECervoMed to Deliver Oral Presentation at the 8th..
16/10/202414:00EDGAR2Form 8-K - Current report
15/10/202414:00GLOBECervoMed Announces Last Patient Last Visit in Phase 2b..
11/10/202414:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/10/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
10/10/202414:44EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/10/202423:12EDGAR2Form S-3 - Registration statement under Securities Act of..
03/10/202423:02EDGAR2Form POS AM - Post-Effective amendments for registration..
03/10/202422:21EDGAR2Form 8-K - Current report
02/10/202414:00GLOBECervoMed to Participate in 3rd Annual ROTH Healthcare..
01/10/202414:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/10/202414:00EDGAR2Form 8-K - Current report
26/9/202414:00GLOBECervoMed to Deliver Late-Breaking Oral Presentations at the..
27/8/202414:30GLOBECervoMed to Participate in Upcoming Investor Conferences
22/8/202414:00GLOBECervoMed Featured in Fortune for Advances in the Treatment..
12/8/202414:00GLOBECervoMed Reports Second Quarter 2024 Financial Results and..
30/7/202414:00GLOBECervoMed to Participate in The Canaccord Genuity 44th Annual..
29/7/202414:00GLOBECervoMed Announces Presentation at AAIC 2024 on Plasma..
17/7/202414:00GLOBECervoMed to Participate in the Emerging Growth Conference
11/7/202414:51GLOBECervoMed to Host Virtual KOL Event on Neflamapimod for..
24/6/202414:00GLOBECervoMed Announces Addition to Russell 2000® and Russell..
11/6/202414:00GLOBECervoMed Announces Completion of Enrollment in Phase 2b..
20/5/202414:00GLOBECervoMed to Appoint William Elder as Chief Financial Officer
15/5/202414:00GLOBECervoMed Reports First Quarter 2024 Financial Results and..
01/4/202414:00GLOBECervoMed Reports Fourth Quarter and Full Year 2023 Financial..
28/3/202413:30GLOBECervoMed Announces Up to $149.4 Million Private Placement..
05/3/202414:00GLOBECervoMed Announces Presentation of Biomarker Data from the..
21/2/202414:00GLOBECervoMed to Participate in the BIO CEO and Investor..
12/2/202414:00GLOBECervoMed Publishes Positive Results from AscenD-LB Phase 2a..
07/2/202414:30GLOBECervoMed Announces Appointment of Industry Leader Joshua..
05/2/202414:00GLOBECervoMed to Participate in the Emerging Growth Conference 67
05/1/202414:00GLOBECervoMed to Participate in the Emerging Growth Conference 66
Apertura: Min: Max:
Chiusura: 8,76

La tua Cronologia

NASDAQ
CRVO
CervoMed
BIT
I07269
INTESA SANPAOLO
BIT
I06593
Intesa Sanpaolo
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network